Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q3 FY21 results · Oct–Dec 2020
Amrutanjan Health Care reported revenue from operations of ₹100.10 crore (up 21.0% from Q3 FY20) and net profit of ₹20.99 crore (up 121.1% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a standalone basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 100.10 | 82.75 | +21.0% | 92.11 | +8.7% |
| Other income | 2.54 | 2.26 | +12.5% | 4.05 | −37.1% |
| Total income | 102.64 | 85.02 | +20.7% | 96.16 | +6.7% |
| Profit before tax | 28.14 | 12.60 | +123.4% | 31.39 | −10.3% |
| Net profit for the period | 20.99 | 9.49 | +121.1% | 23.55 | −10.9% |
| EPS, basic (₹) | 7.18 | 3.25 | +120.9% | 8.06 | −10.9% |
| Net margin (%) | 21.0 | 11.5 | 25.6 |
Standalone
- Filed with BSE
- 11 Feb 2021, 15:34 IST
- Board meeting
- 11 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE